Previous 10 | Next 10 |
ViewRay Announces Conference Call for Second Quarter 2022 Financial Results to be Held After Market on August 2, 2022 PR Newswire CLEVELAND , July 19, 2022 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release o...
ViewRay (NASDAQ:VRAY) said the VA Ann Arbor Healthcare System (VAAAHS) has selected a MRIdian MRI-guided radiation therapy system to expand services at the Lieutenant Colonel Charles S. Kettles VA Medical Center. The system will enable the VA Ann Arbor Cancer Program to offer a...
VA Ann Arbor Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services PR Newswire Represents Second VA Hospital to Offer MRIdian MRI-guided Radiation Therapy Cancer Treatment Directly to Veterans CLEVELAND , June 9, 2022 /PRNews...
ViewRay (NASDAQ:VRAY) said Shin-Matsudo Central General Hospital has bought a MRIdian MRI-guided radiation therapy system for Shin-Matsudo Accuracy Radiation Therapy center in Japan The company said this is its third MRIdian system in Japan. The center expects to begin patient treatments...
Shin-Matsudo Central General Hospital Select's ViewRay's MRIdian® MRI-Guided Radiation Therapy System to Expand Access to Precision Radiation Therapy PR Newswire CLEVELAND , June 7, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced th...
Henry Ford Health Becomes the First Center to Treat Patients with ViewRay's MRIdian A3i System PR Newswire New MRIdian A3i features will enable the Henry Ford team to streamline on-table workflow, reduce treatment times, and expand clinical utility to brain treatments ...
Insiders once again stepped up their purchases to take advantage of prices. Uber’s CEO Dara Khosrowshahi bought 200,000 shares for $5.35 million. Mr. Schultz picked up $10 million worth of Starbucks. There were repeat purchases by the insiders of B. Riley as well. ...
Today, we circle back on a small cap concern called ViewRay for the first time in some three years. Its core product, the MRIdian system, is gaining acceptance and order backlog and revenues continue to increase. The stock has seen some significant insider buying after its recent ...
Gainers: Cullinan Oncology (CGEM) +21%. Concert Pharmaceuticals (CNCE) +20%. Babylon Holdings BBLN +16%. Blue Water Vaccines (BWV) +14%. ViewRay (VRAY) +10%. Losers: Eargo (EAR) -24%. Senseonics (SENS) -14%. Ascendis Pharma (ASND) -11%. Evaxion Biotech...
Clinical Value of MRIdian® MRI-Guided Radiation Therapy in the Treatment of Ultracentral/Central Lung Tumors Presented at ESTRO 2022 PR Newswire Retrospective analysis shows MRIdian's small treatment margins enabled by adaptation and real-time tracking and automat...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...